SLC2A4 and cardiac hypertrophy: As our results showed that Zn(ASA)2 improves LV diabetic heart function not by decreasing myocardial hypertrophy but likely by its action on fibrosis, these observations may in part, explain why the Zn(ASA)2 treatment failed to regulate the expression of myocardial GLUT4 protein.